Literature DB >> 15179361

Potential benefits of the new Leapfrog standards: effect of process and outcomes measures.

John D Birkmeyer1, Justin B Dimick.   

Abstract

OBJECTIVE: The Leapfrog Group standards for evidence-based hospital referral underwent significant revision in 2003. In addition to other changes, risk-adjusted mortality and process of care measures now augment or replace volume standards for some procedures. The objective of this study was to estimate the potential benefits of these newly expanded standards.
METHODS: Leapfrog's 2003 standards were based on minimum volume standards alone for 2 operations (esophagectomy, pancreatectomy), volume standards and a process measure (perioperative beta blockade) for 1 operation (abdominal aortic aneurysm repair), and volume standards coupled with risk-adjusted mortality rates for 2 operations (coronary artery bypass grafting [CABG] and percutaneous coronary intervention [PCI]). We used data from the 2000 Nationwide Inpatient Sample to determine eligible surgical populations, volume-outcome associations, and risk-adjusted hospital mortality rates for the 5 operations. A recent meta-analysis was used to estimate the effectiveness of perioperative beta-blocker use.
RESULTS: Approximately 23,790 patients died in 2000 in the United States undergoing 1 of the 5 procedures. We estimate that full implementation of the Leapfrog standards would have averted 7818 of these deaths: CABG (4089), PCI (3016), elective abdominal aortic aneurysm repair (356), esophageal resection (180), and pancreatic resection (177). For CABG and PCI, standards based on risk-adjusted mortality rates would save at least 5 times more lives than those based on volume criteria alone.
CONCLUSIONS: Widespread implementation of the 2003 Leapfrog standards for evidence-based referral could avert a large number of surgical deaths. For some procedures, standards comprised of process of care or direct outcome measures would be more effective than those based on volume alone.

Entities:  

Mesh:

Year:  2004        PMID: 15179361     DOI: 10.1016/j.surg.2004.03.004

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  57 in total

1.  Accelerating U.S. EHR adoption: how to get there from here. recommendations based on the 2004 ACMI retreat.

Authors:  Blackford Middleton; W Ed Hammond; Patricia F Brennan; Gregory F Cooper
Journal:  J Am Med Inform Assoc       Date:  2004-10-18       Impact factor: 4.497

2.  Reducing avoidable deaths among veterans: directing private-sector surgical care to high-performance hospitals.

Authors:  William B Weeks; Alan N West; Amy E Wallace; Richard E Lee; David C Goodman; Justin B Dimick; James P Bagian
Journal:  Am J Public Health       Date:  2007-10-30       Impact factor: 9.308

Review 3.  Shaping the future of surgery: the role of private regulation in determining quality standards.

Authors:  Rachael A Callcut; Tara M Breslin
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

4.  Relationship between provider volume and outcomes for orthotopic liver transplantation.

Authors:  John E Scarborough; Ricardo Pietrobon; Janet E Tuttle-Newhall; Carlos E Marroquin; Bradley H Collins; Dev M Desai; Paul C Kuo; Theodore N Pappas
Journal:  J Gastrointest Surg       Date:  2008-07-09       Impact factor: 3.452

5.  National trends in esophageal surgery--are outcomes as good as we believe?

Authors:  Geoffrey Paul Kohn; Joseph Anton Galanko; Michael Owen Meyers; Richard Harry Feins; Timothy Michael Farrell
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

6.  [Minimum provider volumes in heart surgery].

Authors:  H J Geissler; F Beyersdorf
Journal:  Chirurg       Date:  2007-11       Impact factor: 0.955

Review 7.  Quality Management and Key Performance Indicators in Oncologic Esophageal Surgery.

Authors:  Ines Gockel; Constantin Johannes Ahlbrand; Michael Arras; Elke Maria Schreiber; Hauke Lang
Journal:  Dig Dis Sci       Date:  2015-07-16       Impact factor: 3.199

8.  Does the use of neoadjuvant therapy for pancreatic adenocarcinoma increase postoperative morbidity and mortality rates?

Authors:  Amanda B Cooper; Abhishek D Parmar; Taylor S Riall; Bruce L Hall; Matthew H G Katz; Thomas A Aloia; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

9.  Impact of Surgical Quality Improvement on Payments in Medicare Patients.

Authors:  Christopher P Scally; Jyothi R Thumma; John D Birkmeyer; Justin B Dimick
Journal:  Ann Surg       Date:  2015-08       Impact factor: 12.969

10.  Relative impact of surgeon and hospital volume on operative mortality and complications following pancreatic resection in Medicare patients.

Authors:  Hemalkumar B Mehta; Abhishek D Parmar; Deepak Adhikari; Nina P Tamirisa; Francesca Dimou; Daniel Jupiter; Taylor S Riall
Journal:  J Surg Res       Date:  2016-05-11       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.